Craig Crosson to Piperazines
This is a "connection" page, showing publications Craig Crosson has written about Piperazines.
Connection Strength
0.019
-
Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma. J Med Chem. 2009 Nov 12; 52(21):6515-8.
Score: 0.019
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.